Shu-Yi Liao, MD, MPH, MS, ScD, ATSF
Founder & Director, Lung Integrative AI & Omics Laboratory at UCLA, Division of Pulmonary, Critical Care, and Sleep Medicine
Division of Pulmonary and Critical Care Medicine
10833 Le Conte Ave 52-257 CHS
Los Angeles, CA 90095
About
Dr. Shu-Yi Liao is a physician-scientist specializing in pulmonary and critical care medicine, with a focus on sarcoidosis and interstitial lung disease. His work centers on understanding disease heterogeneity and progression to improve outcomes in chronic respiratory disease.
His research integrates multi-omics, genomics, and artificial intelligence to uncover disease mechanisms, identify biomarkers, and develop predictive models for precision medicine. His work is supported by multiple grants, including funding from the Foundation for Sarcoidosis Research, the Ann Theodore Foundation, and the NIH (R01 and R21).
Education and Degree(s)
- MD from National Taiwan University, Taipei, Taiwan
- MPH from Harvard School of Public Health
- MS from Harvard School of Public Health
- ScD from Harvard School of Public Health
- Internal Medicine Residency at the University of California, Riverside
- Pulmonary and Critical Care Medicine Fellowship at the University of California, Davis